Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

349results about How to "Reduce expression" patented technology

Application of transcription factor CsPIF7 gene in regulation and control of theanine synthesis and improvement of tea quality

The invention provides application of a transcription factor CsPIF7 gene in regulation and control of theanine synthesis and improvement of tea quality, and belongs to the technical field of agricultural molecular biology. The invention finds that high expression of CsPIF7 can activate expression of TS1 and GS1, so that more theanine can be accumulated in tea leaves; after the expression of CsPIF7 is reduced by a tea tree VIGS technology, the activation and expression of TS1 and GS1 can be reduced, so that the content of theanine in tea leaves is reduced. Furthermore, the tea tree transcription factor CsPIF7 is found to be capable of positively regulating and controlling expression of TS1 and GS1 by utilizing LUC verification, and can be used for regulating and controlling the content of theanine in tea trees and improving the quality of tea leaves.
Owner:GUIZHOU UNIV

Gardenia polysaccharide as well as preparation method and application thereof

The invention relates to gardenia polysaccharide as well as a preparation method and application thereof. The gardenia polysaccharide comprises the following monosaccharide units: rhamnose, glucuronic acid, galacturonic acid, glucose, galactose and arabinose, or mainly comprises rhamnose, glucuronic acid, galacturonic acid, glucose, galactose and arabinose; the molar ratio of rhamnose to glucuronic acid to galacturonic acid to glucose to galactose to arabinose in the gardenia polysaccharide is (3-15): (1-8): (4-18): (1-6): (15-35): (25-70). According to the gardenia polysaccharide, FFA induced mouse primary parenchymal hepatic cell lipid accumulation can be reduced, no obvious cytotoxic effect exists, CDAHFD diet induced hepatic fibrosis can be reduced, and the gardenia polysaccharide has a good effect of preventing and / or treating non-alcoholic steatohepatitis.
Owner:SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES

Application of Wnt2 gene in buffalo ovarian granular cells

PendingCN119592628Apromote proliferationHigh expressionGenetically modified cellsNucleic acid vectorSignaling Pathway GeneGranular cell
The invention discloses application of a Wnt2 gene in buffalo ovarian granular cells, and belongs to the technical field of cell engineering and gene engineering. Wnt2 is taken as a research object, the Wnt2 overexpression vector or Wnt2 siRNA is transfected to the ovarian granulosa cells respectively by constructing the Wnt2 overexpression vector and synthesizing small interfering RNA (Wnt2 siRNA), then changes of signal channel gene mRNA and protein level related to ovarian granulosa cell apoptosis, proliferation and E2 and P4 secretion are detected, and finally phenotypic changes of the ovarian granulosa cells are detected. Results show that Wnt2 can inhibit apoptosis of ovarian granular cells and promote proliferation and E2 and P4 secretion. By exploring the application of the Wnt2 in the ovarian granular cells, the application has good application in researching an ovarian follicle atresia mechanism, initial estrus initiation and the like.
Owner:GUANGXI ZHUANG AUTONOMOUS REGION BUFFALO INST

Application of OsLOX1 gene in regulation and control of drought resistance and seed vigor of rice

The invention discloses application of an OsLOX1 gene in regulation and control of drought resistance and seed vigor of rice, and relates to the technical field of plant genetic engineering. According to the invention, the drought stress tolerance of the mutation line with the OsLOX1 knocked out through CRISPR / Cas9 is lower than that of a wild type line, and along with the increase of the content of hydrogen peroxide (H2O2) and malondialdehyde (MDA) and the reduction of the expression quantity of antioxidant enzyme related genes. In addition, it is found that compared with a wild type, the service life of rice seeds is shortened by knocking out OsLOX1, meanwhile, the content of H2O2 and MDA is increased, and the activity of antioxidant enzyme superoxide dismutase (SOD) and catalase (CAT) is reduced; the method can be used for breeding storage-resistant and drought-resistant rice varieties; important gene resources are provided for cultivating drought-resistant rice varieties and prolonging the service life of seeds.
Owner:福建省农业科学院水稻研究所

Precipitation supported slow-release carbon-based iron fertilizer and preparation method thereof

The invention discloses a precipitation-supported slow-release carbon-based iron fertilizer and a preparation method thereof, and the preparation method specifically comprises the following steps: firstly, putting a biological carapace heavy metal adsorbent into a calcium hydroxide solution for dipping, drying, then putting the biological carapace heavy metal adsorbent into a ferrous sulfate solution for dipping in two times, and finally drying and granulating. Precipitated ferric hydroxide, a ferrous hydroxide mixture and excessive ferric sulfate are uniformly dispersed and attached to the interiors of pore channels of the porous adsorbent, and the excessive ferric sulfate can quickly provide iron ions for antagonistic cadmium and arsenic ion absorption in the early growth stage of rice. Precipitated ferric hydroxide and ferrous hydroxide wrapped by calcium sulfate in the porous adsorbent not only can realize long-acting slow release of iron ions, but also can reduce the oxygen content of soil, and iron ion antagonism and precipitation type adsorption loading modes are carried out in the whole growth process of rice, so that the release period of the iron ions is greatly prolonged, and the soil quality is improved. The iron fertilizer disclosed by the invention has an excellent rice cadmium-arsenic antagonism effect and has an excellent application prospect.
Owner:INST OF SOIL FERTILIZER & RESOURCE ENVIRONMENT JIANGXI ACAD OF AGRI SCI

Construction method and application of modified AAV-8 serotype for retina wide targeting and expression

The invention belongs to the technical field of gene engineering and biology, discloses a modified adeno-associated virus AAV-8 serotype for retina wide targeting and expression, and further relates to construction and application of the modified type. 10 amino acid sequences as shown in SEQ ID NO.3 are inserted between the 590th amino acid and the 591th amino acid of an AAV-8 serotype capsid protein sequence as shown in SEQ ID NO.2, the first, second and tenth amino acids are protected amino acids, and the third to ninth amino acids are amino acid sequences obtained by screening. The modified serotype disclosed by the invention is stronger in fluorescence effect after infection and can be obviously and intuitively observed, an exogenous gene can be widely and efficiently expressed in a specific targeted tissue retina whole region, and the expression efficiency is greatly improved under the condition of using the same virus amount. And compared with a wild serotype, the serotype has better and wider targeted tissue expression and less non-targeted tissue expression.
Owner:SHANGHAI OPHTHAL-BRIGHT BIOMEDICINE TECH

Application of turnip crinkling virus P8 in inhibiting degradation of mRNA decay substrate

ActiveCN119614626AIt has silence suppression functionavoid degradationSsRNA viruses positive-senseVirus peptidesMRNA DecayCoding region
The invention provides application of a P8 gene, or a P8 gene coding protein, or a recombinant vector or host bacteria containing a P8 gene coding region in improvement of GFP (Green Fluorescent Protein) expression quantity and / or inhibition of degradation of an mRNA (Messenger Ribonucleic Acid) attenuated substrate taking GFP as a reporter gene. The research finds that the P8 has a silence inhibition function, can inhibit degradation of a nonsense mediated mRNA decay substrate taking GFP as a reporter gene and degradation of an endogenous nonsense mediated mRNA decay (NMD) substrate of arabidopsis thaliana, can improve the mRNA expression quantity of AT1G0106020, RPS6, SMG7, AT5G35490, AT5G64430, AT1G36730, AT4G3900 and AT5G22570, and can reduce the expression quantity of AT1G72450 and AT2G400, and the research result lays a foundation for clarification of the function of the P8.
Owner:SANYA RES INST OF CHINESE ACAD OF TROPICAL AGRI +1

Medicine for treating osteoarthritis

PendingCN119614663AExcellent cartilage repair functionnon-cytotoxicOrganic active ingredientsMicrobiological testing/measurementPharmacy medicineArginine
The invention discloses a medicine for treating osteoarthritis, and belongs to the field of medicine, the medicine comprises a reagent capable of stimulating chondrocyte development, and the medicine L-arginine can promote expression of chondrocyte anabolic factors and reduce expression of cartilage degradation markers, so that chondrocytes are protected to a certain extent; in addition, the medicine provided by the invention has an excellent cartilage repair function, can inhibit the progress of degenerative osteoarthritis, has good biocompatibility, and has no cytotoxicity to cartilage cells.
Owner:THE SECOND AFFILIATED HOSPITAL OF ANHUI MEDICAL UNIV

Preparation method of fusion protein of salmonella typhimurium flagellin and Seneca virus antigen

The invention belongs to the technical field of biology, and discloses a preparation method of fusion protein of salmonella typhimurium flagellin and Seneca virus antigen. Escherichia coli Rosetta (DE3) is selected as a host, a salmonella typhimurium flagellin gene and a Seneca virus antigen gene are fused and are cloned to a pET-28a (+) vector after codon optimization, the obtained fusion protein keeps the flagellin adjuvant activity, the solubility and the expression level of VP2 are improved, the yield can reach 40 mg / L, and the fusion protein can be used for preparing a recombinant vector. The expression and purification process cost is greatly reduced. The fusion protein provided by the invention can activate a TLR5 pathway and mouse macrophages, is simple in production process and low in cost, and has important significance on research and production of Seneca virus subunit vaccines.
Owner:LANZHOU UNIV

Cyclic peptide derivative as well as preparation method and application thereof

The invention relates to the technical field of biological materials, in particular to a cyclic peptide derivative and a preparation method and application thereof. The cyclopeptide derivative provided by the invention simultaneously comprises a hydrophobic cyclopeptide structure and a hydrophilic pantothenic acid structure which are combined through a covalent ester bond; due to the structure, excellent stability is achieved, and the problems that pantothenic acid is unstable and irritant are effectively solved; after entering the skin, the derivative can be hydrolyzed into pantothenic acid under the action of esterase, and can play a role without oxidative conversion of panthenol. Secondly, the cyclic peptide derivative disclosed by the invention has good biological safety; in an inflammatory cell model, the derivative can more effectively reduce expression of inflammatory factors, and antioxidant activity research shows that the derivative has a strong free radical inhibition effect and can exert excellent anti-inflammatory and antioxidant effects.
Owner:RUNHUI BIOTECHNOLOGY (WEIHAI) CO LTD

Fluorescent quantitative PCR (polymerase chain reaction) detection method and detection kit for detecting differentiation potential of induced pluripotent stem cells

The invention discloses a fluorescent quantitative PCR (polymerase chain reaction) detection method and a detection kit for detecting differentiation potential of induced pluripotent stem cells. The detection method comprises the following steps: S1, preparing an embryoid body by utilizing iPSC (induced pluripotent stem cells); s2, extracting RNA (Ribonucleic Acid) of the iPSC and the embryoid body; s3, respectively carrying out reverse transcription on the iPSC and RNA of an embryoid body to obtain cDNA; s4, establishing a fluorescent quantitative PCR reaction system by adopting the primer composition in claim 1; s5, carrying out fluorescent quantitative PCR (Polymerase Chain Reaction) detection on the cDNA in S3; and S6, analyzing a result. The detection kit disclosed by the invention can be used for rapidly and accurately evaluating the differentiation potential of the induced pluripotent stem cells, and is suitable for large-scale cell differentiation research and clinical application.
Owner:ZHEJIANG HENGYU BIOTECHNOLOGY CO LTD

Application of arabinoxylan and composition of arabinoxylan

The invention provides an application of arabinoxylan, and the application is selected from any one of the following: an application of arabinoxylan in preparation of a medicine for improving dyskinesia, the dyskinesia including dyskinesia, and an application of arabinoxylan in preparation of a medicine for improving dyskinesia. The application is used for preparing medicines for improving the expression quantity of TH and BDNF in the brain nigra and reducing the expression quantity of alpha-syn, IFN-gamma and IL1-beta proteins; the application is used for preparing a medicine for improving brain tissue nigra neuron damage; the application is used for preparing medicines for improving the expression quantity of BDNF in serum and reducing the expression quantity of TNF-alpha, IL-1beta and NF-kappa B proteins; the compound is used for preparing a medicine for treating Parkinson's disease. According to the technical scheme, a new thought is provided for clinical medication selection of the Parkinson's disease.
Owner:SHANGHAI CYPRIT BIOTECHNOLOGY CO LTD

SiRNA for inhibiting PLN gene expression and conjugate and application thereof

The invention belongs to the field of biological medicine, and relates to siRNA for inhibiting PLN gene expression and a conjugate, the siRNA comprises a positive-sense strand and an antisense strand, the positive-sense strand comprises a nucleotide sequence I, and the antisense strand comprises a nucleotide sequence II; each nucleotide in the nucleotide sequence I and the nucleotide sequence II is modified or unmodified nucleotide; the nucleotide sequence I and the nucleotide sequence II are at least partially reversely complementary to form a double-stranded region; the nucleotide sequence I is basically consistent with a first section of nucleotide sequence, and the first section of nucleotide sequence is a section of nucleotide sequence with the length of at least 19 nucleotides in mRNA expressed by the PLN gene. The siRNA and the conjugate and the pharmaceutical composition thereof disclosed by the invention can effectively prevent and / or treat diseases associated with PLN expression, such as heart failure, cardiomyopathy, arrhythmia and the like, and have a good patent medicine prospect.
Owner:BEIJING GLYEXO GENE TECH CO LTD

Antisense oligonucleotide and polypeptide conjugate as well as preparation method and application thereof

The invention discloses a conjugate of antisense oligonucleotide and polypeptide as well as a preparation method and application of the conjugate, belongs to the technical field of biological medicine, and provides the conjugate of antisense oligonucleotide and polypeptide, the structural general formula of the conjugate of antisense oligonucleotide and polypeptide is as shown in formula (I), O is antisense oligonucleotide, L is a connexon, and P is polypeptide; the antisense oligonucleotide is a nucleotide sequence obtained by modifying thiophosphate and 2 '-O-methyl on the basis of a nucleotide sequence as shown in SEQ ID NO.1 or a nucleotide sequence as shown in SEQ ID NO.2; and the amino acid sequence of the polypeptide is as shown in SEQ ID NO.3. According to the conjugate of the antisense oligonucleotide and the polypeptide, a phosphodiester bond of RNA is catalyzed by the polypeptide P to break, the antisense oligonucleotide O is complementarily paired with a frame-shift element, the polypeptide P is brought to the vicinity of the frame-shift element for targeted cleavage, and a linker L is responsible for coupling, sequence-specific targeted degradation of pathogenic RNA and destruction of the expression condition of RNA in cells.
Owner:UNIV OF CHINESE ACAD OF SCI

Lactobacillus salivarius combination CCFM1398 for regulating and controlling bone homeostasis and relieving bone resorption and metagen of lactobacillus salivarius combination CCFM1398

The invention discloses combined lactobacillus salivarius CCFM1398 for regulating and controlling bone homeostasis and relieving bone resorption and a metagen of the combined lactobacillus salivarius CCFM1398, and belongs to the technical field of microorganisms. The combined lactobacillus salivarius CCFM1398 provided by the invention is separated from oral dental plaque of healthy teenagers, has the effects of relieving bone resorption and resisting inflammation, and is specifically reflected in that expression of protein level and gene level of MC3T3-E1 cell osteoprotegerin (OPG) is improved in vitro; the bone absorption amount of orthodontic bone absorption rat alveolar bone is reduced, the number of alveolar bone osteoclasts is reduced, and the level of rat serum OPG is improved; the secretion of inflammatory factors TNF-alpha, IL-6 and MPO of the orthodontic bone absorption rat is reduced; and the pathological condition of orthodontic bone absorption rat alveolar bone tissue is improved. Therefore, the combined lactobacillus salivarius has a huge application prospect in products for relieving bone resorption and assisting in inhibiting periodontal tissue inflammation.
Owner:JIANGNAN UNIV

Asiatic acid derived ceramide as well as synthesis method and application thereof

The invention belongs to the technical field of biological medicines, and discloses ceramide derived from asiatic acid, which has a structure shown in a general formula I or an isomer shown in the general formula I: # imgabs0, in which R1 is selected from one of the following structures: # imgabs1 # R2 is a hydroxyl group or a hydrogen atom. The invention further discloses a synthesis method and application of the ceramide derived from the asiatic acid, the asiatic acid or madecassic acid fragment with good fat solubility is introduced, the solubility of the ceramide is improved, and the ceramide is more convenient to apply in a formula; the compound disclosed by the invention has an obvious inhibiting effect on interleukin 6 (IL-6) inflammatory factors, can also inhibit the overexpression of a TRPV1 receptor of sensitive skin, and can obviously reduce the expression of hyaluronidase, so that the compound has a very good soothing effect.
Owner:SHENZHEN DIKEMAN BIOTECHNOLOGY CO LTD

Multifunctional DNA nano-material, preparation method thereof and application of multifunctional DNA nano-material in treatment of traumatic brain injury secondary encephaledema

The invention belongs to the field of biological materials, and particularly relates to a multifunctional DNA nanometer material, a preparation method and application of the multifunctional DNA nanometer material in treatment of traumatic brain injury secondary encephaledema. The multifunctional DNA nano material comprises a plurality of deoxyribozyme (DNAzyme) targeting C1q mRNA (messenger Ribonucleic Acid) and a repeating unit which is integrally connected with G-quadruplex / Hemin in series, wherein the G-quadruplex / Hemin is labeled by streptavidin SA and biotin and is used for scavenging free radicals. The DNAzyme for silencing the C1q gene of the mouse is designed on the basis of a bioinformatics method, and the C1q gene overexpressed in an inflammation model can be knocked down to an approximate normal level. The RCA technology mediated self-assembled nano material SA-B / H has excellent enzyme mimetic activity, can effectively remove free radicals such as H2O2 and O2 <.->, and has the potential of in-vivo oxidation resistance. In-vitro experiments prove that SA-B / H can effectively relieve high-level oxidative stress of cells caused by H2O2 stimulation.
Owner:TIANJIN UNIV

Mild anti-aging composition as well as preparation method, cosmetics and application thereof

The invention provides a mild anti-aging composition as well as a preparation method, cosmetics and application thereof, and belongs to the technical field of cosmetics. The mild anti-aging composition disclosed by the invention is prepared from hydroxyl pinacolone 9-cis retinoate and Gravi-A, wherein the Gravi-A is prepared from hydroxyl pinacolone retinoate and retinol propionate according to a mass ratio of 5 to 9. The composition disclosed by the invention can have a synergistic anti-aging effect in a specific proportion range; particularly, when the mass ratio of the hydroxyl pinacolone 9-cis-retinoate to the Gravi-A is 8: 2, under the condition that no anti-irritation component is added, the expression of molecular targets of inflammatory reaction can be effectively reduced, so that the irritation to the skin is reduced. The composition not only realizes an excellent anti-aging effect, but also considers the mild demand of skin, reduces the dosage of hydroxypinacolone 9-cis-retinoate, reduces the cost, and has a wide prospect when being applied to preparation of cosmetics.
Owner:INERTIA SHANGHAI BIOTECHNOLOGY CO LTD +1

Application of chrysin in preparation of medicine for treating mammalian NFAT2 related diseases

The invention relates to an application of chrysin in preparation of drugs for treating mammalian NFAT2 related diseases. It is confirmed for the first time that chrysin shows significant anti-inflammatory activity in a KD mouse model and a cell injury model. This effect may be achieved by modulating NFAT2. The discovery has important significance for understanding and potentially treating the vascular endothelial injury of the Kawasaki disease, and a new insight is provided for treating the Kawasaki disease by using traditional Chinese medicines.
Owner:SOOCHOW UNIV AFFILIATED CHILDRENS HOSPITAL

Lactobacillus rhamnosus MBP01 capable of preventing and treating haemorrhoids and application of lactobacillus rhamnosus MBP01

The invention belongs to the technical field of microorganisms, and particularly relates to lactobacillus rhamnosus MBP01 capable of preventing and treating haemorrhoids and application of the lactobacillus rhamnosus MBP01. The invention provides application of the lactobacillus rhamnosus MBP01 with the preservation number of GDMCC NO: 64725 or a microecological preparation of the lactobacillus rhamnosus MBP01 in preparation of products for prevention, treatment, adjuvant treatment or prognosis nursing of haemorrhoids. The lactobacillus rhamnosus MBP01 provided by the invention can improve the weight decline trend of hemorrhoid model mice, alleviate anorectal swelling, reduce the rectum coefficient of a treatment experiment group, relieve the damage of rectum tissues, down-regulate the levels of TNF-alpha, IL-2, PGE2 and NO in a treatment experiment and the levels of NO, IL-1 and IL-4 in a prevention experiment, and reduce the expression quantities of TNF-alpha and IL-6 at the same time. Therefore, the lactobacillus rhamnosus MBP01 has a certain effect of treating and preventing the hemorrhoids of the mice.
Owner:MAYINGLONG PHARMA GROUP

Image generation model training method and device, equipment and medium

The invention belongs to the field of artificial intelligence, and relates to an image generation model training method comprising the following steps: obtaining a sample image and structural feature information corresponding to the sample image; inputting the structural feature information as a constraint condition into a preset diffusion model to generate a plurality of prediction images; based on an intra-class contrast learning strategy, performing integration processing on the plurality of prediction images and the sample image to obtain a loss function; adjusting parameters of the diffusion model based on the loss function, and returning to execute the step of inputting the structural feature information as the constraint condition into the preset diffusion model until the loss function is obtained until the convergence of the loss function reaches a convergence threshold value; and determining the diffusion model corresponding to the condition that the loss function reaches a convergence threshold as an image generation model. The invention further provides a device, equipment and a medium. In addition, the invention also relates to a block chain technology, and the sample image and the structural feature information can be stored in a block chain. According to the invention, the image generation accuracy can be improved.
Owner:PING AN TECH (SHENZHEN) CO LTD

Lactobacillus salivarius combination CCFM1397 capable of improving osteoblast activity and relieving bone resorption and periodontal tissue injury and metagen of lactobacillus salivarius combination CCFM1397

The invention discloses a combined lactobacillus salivarius CCFM1397 for improving osteoblast activity and relieving bone resorption and periodontal tissue damage and a metagen thereof, and belongs to the technical field of microorganisms. The lactobacillus salivarius combination CCFM1397 provided by the invention is separated from oral dental plaque of healthy teenagers, has the effects of relieving bone resorption and resisting inflammation, and is specifically reflected in that: the expression of MC3T3-E1 cell osteoprotegerin (OPG) protein and gene level is improved in vitro; the bone absorption amount of orthodontic bone absorption rat alveolar bone is reduced, the number of alveolar bone osteoclasts is reduced, and the level of rat serum OPG is improved; the secretion of inflammatory factors IL-1beta, IL-6 and TNF-alpha and myeloperoxidase MPO of the orthodontic bone absorption rats is reduced; and the pathological condition of orthodontic bone absorption rat alveolar bone tissue is improved. Therefore, the combined lactobacillus salivarius has a huge application prospect in products for relieving bone resorption and assisting in inhibiting periodontal tissue inflammation.
Owner:JIANGNAN UNIV

Application of small molecule compound in preparation of medicine for treating fibrosis or fibrosis-related diseases

The invention belongs to the technical field of medical treatment and medicines, and particularly discloses application of a small molecule compound C25H20FN7O6S in preparation of medicines for treating fibrosis or fibrosis-related diseases, and the fibrosis refers to skin fibrosis and / or pulmonary fibrosis. The small molecule compound C25H20FN7O6S inhibits collagen synthesis and fibroblast activation through an MAPK pathway so as to alleviate skin fibrosis, and can improve physiological indexes caused by skin fibrosis diseases, including reduction of expression quantity of skin fibrosis related proteins COL1A1 and alpha-SMA, alleviation of weight loss, improvement of skin corium layer thickening, collagen increase and appendage reduction. Meanwhile, the C25H20FN7O6S can be used for inhibiting the pulmonary fibrosis. The invention lays a foundation for treatment of diseases including systemic sclerosis and characterized by skin fibrosis and / or pulmonary fibrosis.
Owner:ZHONGSHAN HOSPITAL FUDAN UNIV

TsRNA marker for diagnosing and evaluating myocardial aging, kit and application of tsRNA marker

The invention discloses a tsRNA marker for diagnosing and evaluating myocardial aging, a kit and application of the tsRNA marker. The application of the tsRNA marker comprises one or more of the following applications: A1) application in preparation of a product for diagnosing myocardial aging; a2) in preparation of products for screening myocardial aging; a3) in preparation of a product for treating myocardial aging; a4) in preparation of myocardial aging condition assessment products; a5) in preparation of products for identifying and distinguishing myocardial aging and other heart diseases; the tsRNA marker is tsRNA-5006c-LysCTT, and the nucleotide sequence of the tsRNA marker is as shown in SEQ ID No. 1. The expression quantity of the tsRNA marker provided by the invention in the plasma of a myocardial aging patient is obviously increased compared with that of a healthy control person, which indicates that tsRNA-5006c-LysCTT has the potential to be used as the myocardial aging biomarker.
Owner:SECOND MEDICAL CENT OF CHINESE PLA GENERAL HOSPITAL

Additive containing amino acid complexing potassium and magnesium as well as preparation method and application of additive

The invention provides an additive containing amino acid complexed potassium and magnesium as well as a preparation method and application of the additive, and relates to the technical field of feed additives. The additive containing amino acid complexed potassium magnesium is prepared from the following raw materials in parts by weight: 45-55 parts of amino acid complexed potassium magnesium, 15-25 parts of sorbitol, 5-15 parts of sodium citrate, 2-4 parts of guanidinoacetic acid, 2-4 parts of dihydropyridine and 10-20 parts of glucose, wherein the amino acid complexed potassium magnesium is prepared from amino acid, potassium hydroxide and magnesium chloride. The prepared additive containing amino acid complexed potassium and magnesium can improve the anti-stress capability of chickens, can reduce the feed conversion ratio and the death rate when being used in chicken feed, reduces the damage to the chickens caused by stress reaction, and also can reduce the expression of inflammatory factors and improve the expression of anti-inflammatory cytokines, thereby improving the immunity of the organism.
Owner:山东鑫谷健康产业有限公司 +1

Lactobacillus paracasei strain and application thereof

The invention relates to the technical field of microorganisms, in particular to a lactobacillus paracasei strain and application thereof. The preservation number of the lactobacillus paracasei strain is CGMCC (China General Microbiological Culture Collection Center) No.27975. The lactobacillus paracasei disclosed by the invention can tolerate an oral environment, inhibit proliferation of streptococcus mutans and remarkably inhibit adhesion of the streptococcus mutans on a hydroxyapatite tooth model; the level of producing water-insoluble exopolysaccharides by streptococcus mutans is reduced, the formation of a dental plaque biofilm caused by streptococcus mutans is effectively reduced, the content of a mature dental plaque biofilm is reduced, and the biofilm is not easy to form; the expression quantity of cariogenic genes gtfB, gtfC, gtfD, ftf and LuxS of streptococcus mutans can be obviously reduced.
Owner:COREE CO LTD

Tamarix ramosissima PDS gene VIGS silencing system as well as construction method and application thereof

The invention discloses a tamarix ramosissima PDS gene VIGS silencing system as well as a construction method and application thereof, and relates to the technical field of plant genetic engineering. The sequence of the specific nucleotide fragment for silencing the PDS gene of tamarix ramosissima disclosed by the invention is as shown in SEQ ID NO. 1. According to the invention, a specific nucleotide fragment for silencing the PDS gene of tamarix ramosissima is connected to a pTRV2 vector to construct a vector pTRV2: TrPDS, namely a VIGS silencing system of the PDS gene of tamarix ramosissima. The result of the embodiment shows that the expression quantity of the PDS gene in the Bensi tobacco leaves silenced by the VIGS silencing system is obviously reduced, so that the white spot whitening phenomenon of the leaves is caused. The invention establishes a low-cost, short-period, easy-to-operate and high-efficiency VIGS virus silencing system of tamarix chinensis, and can be used for preliminary screening and identification of tamarix chinensis functional genes.
Owner:XINJIANG AGRI UNIV

Tea tree CsGRF7 gene and application thereof

The invention discloses a tea tree CsGRF7 gene and application thereof. The nucleotide sequence of the CDS sequence of the CsGRF7 gene is shown as SEQ ID NO. 1. According to the invention, a precursor sequence of the tea tree CsGRF7 gene or CsmiR396a gene is connected to a carrier and is transformed to arabidopsis thaliana through agrobacterium tumefaciens mediation, and a transgenic line is obtained through screening and culturing. The result shows that CsmiR396a and CsGRF7 in the tea tree both participate in the GA approach to regulate and control the development of flowers. The invention further discloses application of the precursor sequence of the tea tree CsmiR396a gene to interference of CsGRF7 gene expression in participation in regulation and control of plant flower development in a GA (Genetic Acid) way.
Owner:WUHAN POLYTECHNIC UNIVERSITY

Targeted nano delivery system for pulmonary fibrosis treatment and preparation method thereof

The invention discloses a targeted nano delivery system for pulmonary fibrosis treatment and a preparation method of the targeted nano delivery system. The lung targeting nano delivery system comprises a carrier and a substance A, the carrier is a nano-particle formed by TM2 or a nano-particle formed by TM2 and DOPE (Dioctyl Olefin Polyethylene); the structural formula of the TM2 is shown as a formula I; the substance A is selected from at least one of the following substances: 1) a substance for inhibiting the expression of a TTC3 gene, 2) a substance for knocking out the TTC3 gene, and 3) a substance for inhibiting the activity or content of the TTC3. The targeted nano-delivery system can reach the deep part of lung tissue through oral trachea administration to realize the effect of safely and effectively delivering drugs.
Owner:BEIJING NORMAL UNIVERSITY